Transo-Pharm focus on API’s for the generic market; a distinctive offer has been built by this privately owned company over many years. Their unique capability to offer regulatory support, combined with the shared service provided by our Chemical and Regulatory experts, means that our clients are supported within the framework of ever increasing regulation.

Learn More

Ask A Technical Question

About this product

Estriol has been shown to lower the risk of UTIs and other urogenital symptoms

Make an Enquiry